5-HT1A receptors mediate (+)8-OH-DPAT-stimulation of extracellular signal-regulated kinase (MAP kinase) in vivo in rat hypothalamus: Time dependence and regional differences

Brain Research

Volumn 1183, Issue 1, 2007, Pages 51-59

  Crane, James W ^a   Shimizu, Keiko ^a   Carrasco, Gonzalo A ^a   Garcia, Francisca ^a   Jia, Cuihong ^a   Sullivan, Nicole R ^a   D'Souza, Deborah N ^a   Zhang, Yahong ^a   Van de Kar, Louis D ^a   Muma, Nancy A ^a   Battaglia, George ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Amygdala; Dorsal raphe; ERK; Hippocampus; Hypothalamus; pERK

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; MITOGEN ACTIVATED PROTEIN KINASE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1 AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN AGONIST;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; ENZYME ACTIVATION; HIPPOCAMPUS; HYPOTHALAMUS; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; STATISTICAL SIGNIFICANCE; ANIMAL; ANTERIOR HYPOTHALAMUS; BIOSYNTHESIS; DENSITOMETRY; DRUG EFFECT; ENZYMOLOGY; PHYSIOLOGY; RAPHE NUCLEUS; STIMULATION; WESTERN BLOTTING;

RATTUS;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AMYGDALA; ANIMALS; BLOTTING, WESTERN; DENSITOMETRY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HIPPOCAMPUS; HYPOTHALAMUS; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGONISTS; STIMULATION, CHEMICAL;

EID: 36048977918     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.07.101     Document Type: Article

References (45)

1. Andrade R., Malenka R.C., and Nicoll R.A. A G protein couples serotonin and GABAB receptors to the same channels in hippocampus. Science 234 (1986) 1261-1265
2. 1A antagonists. Trends Neurosci. 19 (1996) 378-383
3. Aznar S., Qian Z., Shah R., Rahbek B., and Knudsen G.M. The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Res. 959 (2003) 58-67
4. Berman R.M., Anand A., Cappiello A., Miller H.L., Hu X.S., Oren D.A., and Charney D.S. The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial. Biol. Psychiatry 45 (1999) 1170-1177
5. 1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins. J. Pharmacol. Exp. Ther. 265 (1993) 16-23
6. 1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J. Biol. Chem. 270 (1995) 18691-18699
7. Chen J., Shen C., and Meller E. 5-HT1A receptor-mediated regulation of mitogen-activated protein kinase phosphorylation in rat brain. Eur. J. Pharmacol. 452 (2002) 155
8. Clarke W.P., De Vivo M., Beck S.G., Maayani S., and Goldfarb J. Serotonin decreases population spike amplitude in hippocampal cells through a pertussis toxin substrate. Brain Res. 410 (1987) 357-361
9. 1A receptor immunoreactivity in hypothalamic neurons involved in body weight control. NeuroReport 13 (2002) 945-951
10. Commons K.G., Connolley K.R., and Valentino R.J. A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology 28 (2003) 206-215
11. Cowen D.S., Johnson-Farley N.N., and Travkina T. 5-HT receptors couple to activation of Akt, but not extracellular-regulated kinase (ERK), in cultured hippocampal neurons. J. Neurochem. 93 (2005) 910-917
12. Davis M., and Myers K.M. The role of glutamate and gamma-aminobutyric acid in fear extinction: clinical implications for exposure therapy. Biol. Psychiatry 52 (2002) 998-1007
13. 1A binding sites with G regulatory proteins. Biochem. Pharmacol. 39 (1990) 7-18
14. Flood D.G., Finn J.P., Walton K.M., Dionne C.A., Contreras P.C., Miller M.S., and Bhat R.V. Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system. J. Comp. Neurol. 398 (1998) 373-392
15. 1A receptor involves distinct signalling cascades. Biochem. J. 330 (1998) 489-495
16. Gioia M., Galbiati S., Rigamonti L., Moscheni C., and Gagliano N. Extracellular signal-regulated kinases 1 and 2 phosphorylated neurons in the tele- and diencephalon of rat after visceral pain stimulation: an immunocytochemical study. Neurosci. Lett. 308 (2001) 177-180
17. Gioia M., Moscheni C., Galbiati S., and Gagliano N. Immunocytochemical localization of extracellular signal-regulated kinases 1 and 2 phosphorylated neurons in the brainstem of rat following visceral noxious stimulation. Neurosci. Lett. 349 (2003) 167-170
18. 1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416 (2002) 396-400
19. Hammack S.E., Schmid M.J., LoPresti M.L., Der-Avakian A., Pellymounter M.A., Foster A.C., Watkins L.R., and Maier S.F. Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. J. Neurosci. 23 (2003) 1019-1025
20. Hensler J.G. Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci. 72 (2003) 1665-1682
21. Hsiung S.C., Adlersberg M., Arango V., Mann J.J., Tamir H., and Liu K.P. Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase. J. Neurochem. 87 (2003) 182-194
22. Huang Y.Y., Martin K.C., and Kandel E.R. Both protein kinase A and mitogen-activated protein kinase are required in the amygdala for the macromolecular synthesis-dependent late phase of long-term potentiation. J. Neurosci. 20 (2000) 6317-6325
23. 3H]-8-OH-DPAT. Pharmacol. Biochem. Behav. 68 (2001) 221-227
24. Kholodenko B.N. Four-dimensional organization of protein kinase signaling cascades: the roles of diffusion, endocytosis and molecular motors. J. Exp. Biol. 206 (2003) 2073-2082
25. Kushwaha N., and Albert P.R. Coupling of 5-HT1A autoreceptors to inhibition of mitogen-activated protein kinase activation via G beta gamma subunit signaling. Eur. J. Neurosci. 21 (2005) 721-732
26. La Cour C.M., El M.S., Hanoun N., Hamon M., and Lanfumey L. Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain. Mol. Pharmacol. 70 (2006) 1013-1021
27. 1A receptors in the rat brain: lack of effect by repeated injections of fluoxetine. Brain Res. 769 (1997) 141-151
28. Lopez-Ilasaca M. Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades. Biochem. Pharmacol. 56 (1998) 269-277
29. Lu K.T., Walker D.L., and Davis M. Mitogen-activated protein kinase cascade in the basolateral nucleus of amygdala is involved in extinction of fear-potentiated startle. J. Neurosci. 21 (2001) RC162
30. Lu L., Hope B.T., Dempsey J., Liu S.Y., Bossert J.M., and Shaham Y. Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat. Neurosci. 8 (2005) 212-219
31. Markstein R., Hoyer D., and Engel G. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol. 333 (1986) 335-341
32. Matsuoka M., Itoh H., and Kaziro Y. Characterization of the human gene for Gx alpha, a pertussis toxin-insensitive regulatory GTP-binding protein. J. Biol. Chem. 265 (1990) 13215-13220
33. 1A receptors coupled to mitogen-activated protein kinase. Eur. J. Pharmacol. 424 (2001) 13-17
34. 1A receptor/Gibgamma stimulates mitogen-activated protein kinase via NAD(P)H oxidase and reactive oxygen species upstream of Src in Chinese hamster ovary fibroblasts. Biochem. J. 347 (2000) 61-67
35. 1A receptors activate a potassium conductance in rat ventromedial hypothalamic neurones. Eur. J. Pharmacol. 210 (1992) 209-212
36. Penington N.J., Kelly J.S., and Fox A.P. Whole-cell recordings of inwardly rectifying K+ currents activated by 5-HT1A receptors on dorsal raphe neurones of the adult rat. J. Physiol. 469 (1993) 387-405
37. 1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins. J. Pharmacol. Exp. Ther. 288 (1999) 98-106
38. Schafe G.E., Atkins C.M., Swank M.W., Bauer E.P., Sweatt J.D., and LeDoux J.E. Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning. J. Neurosci. 20 (2000) 8177-8187
39. 1A receptors in vivo. J. Neurosci. 20 (2000) 3095-3103
40. Sramek J.J., Frackiewicz E.J., and Cutler N.R. Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxiety. Clin. Ther. 19 (1997) 498-506
41. Sullivan N.R., Crane J.W., Damjanoska K.J., Carrasco G.A., D'Souza D.N., Garcia F., and Van de Kar L.D. Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 371 (2005) 18-26
42. 7 receptors. Br. J. Pharmacol. 130 (2000) 409-417
43. Uphouse L. Female gonadal hormones, serotonin, and sexual receptivity. Brain Res. Rev. 33 (2000) 242-257
44. Uphouse L., Caldarola-Pastuszka M., Maswood S., Andrade M., and Moore N. Estrogen-progesterone and 8-OH-DPAT attenuate the lordosis-inhibiting effects of the 5-HT1A agonist in the VMN. Brain Res. 637 (1994) 173-180
45. Vicentic A., Li Q., Battaglia G., and Van de Kar L.D. WAY-100635 inhibits 8-OH-DPAT stimulated oxytocin, ACTH, and corticosterone, but not prolactin secretion. Eur. J. Pharmacol. 346 (1998) 261-266